Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data
- 7 December 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Psoriasis and Psoriatic Arthritis®
- Vol. 9 (1) , 5-15
Abstract
Background: Electronic health records (EHRs) offer the possibility of using data entry templates to simultaneously document routine clinical care and capture disease-specific measures as discrete data elements that can be used for health services research (HSR). The objective of this study was to determine factors associated with meaningful treatment escalation (MTE) of psoriasis as a pilot study for future real-world HSR studies. Methods: We conducted a retrospective, observational cohort study of psoriasis patients by using data collected during routine clinical care from an EHR using EpiCare® SmartForms. The psoriasis SmartForm records psoriasis disease severity measures and descriptive findings to generate visit notes. These data were extracted and analyzed to identify factors associated with MTE, defined as changing or adding, phototherapy, systemic, or biologic therapy. Results: 473 psoriasis patients met study criteria; 239 underwent MTE between their first and third observed visits. Patients who experienced MTE had more severe disease at Visit 1—assessed by BSA, pPGA, oPGA, and a patient-reported disease severity measure--than patients who did not experience MTE. Other factors associated with MTE included use of topicals only or no active treatment at Visit 1, palmoplantar disease, and involvement of other difficult-to-treat body areas. Patients who underwent MTE experienced larger improvements in disease severity than those who did not. Conclusions: This study highlights how data collected during routine clinical practice can be readily used for real-world retrospective HSR when disease measures are captured as discrete elements. This approach could provide a cost-effective platform to conduct real-world HSR.Keywords
Funding Information
- Eli Lilly and Company
This publication has 13 references indexed in Scilit:
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- The Evolving Use of Electronic Health Records (EHR) for ResearchSeminars in Radiation Oncology, 2019
- Examining the Use of Real‐World Evidence in the Regulatory ProcessClinical Pharmacology & Therapeutics, 2019
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbiditiesJournal of the American Academy of Dermatology, 2019
- Promises and pitfalls of electronic health record analysisDiabetologia, 2017
- With the Merit-Based Incentive Payment System, Pay for Performance Is Now National PolicyAnnals of Internal Medicine, 2017
- The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trialsJournal of the European Academy of Dermatology and Venereology, 2016
- Risk of Serious Infection With Biologic and Systemic Treatment of PsoriasisJAMA Dermatology, 2015
- "Smart Forms" in an Electronic Medical Record: Documentation-based Clinical Decision Support to Improve Disease ManagementJournal of the American Medical Informatics Association, 2008
- Multiple Imputation for Nonresponse in Surveys1987